PCRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Pacira Biosciences Inc and Microsoft Corp in 2026
PCRX
Pacira Biosciences Inc
$23.86
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | PCRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.03B | N/A | PCRX |
| P/E Ratio | 149.13 | 26.32 | MSFT |
| EPS (TTM) | $0.16 | $15.97 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 63.2% | 68.6% | MSFT |
Analyze PCRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCRX or MSFT a better investment?
Comparing PCRX and MSFT: Pacira Biosciences Inc has a market cap of $1.03B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCRX and MSFT?
PCRX (Pacira Biosciences Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCRX or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.3x vs 149.1x).
Which is growing faster: PCRX or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for PCRX.
Which company is more profitable: PCRX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 63.2% for PCRX.
Which is the larger company: PCRX or MSFT?
Pacira Biosciences Inc (PCRX) is larger with a market cap of $1.03B compared to N/A for MSFT.
Should I buy PCRX or MSFT in 2026?
Both PCRX and MSFT have investment merit. PCRX trades at $23.86 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCRX and MSFT stock?
Key differences: Market Cap ($1.03B vs N/A), P/E Ratio (149.1x vs 26.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (63.2% vs 68.6%).